29 research outputs found
Summary of snakes known to cause venom-induced consumption coagulopathy, the procoagulant toxin, and the factor deficiencies that have been reported (with permission from WikiToxin).
<p>aPTT β activated partial thromboplastin time, CT β clotting time, VCT β venous clotting time, FDP β fibrinogen degradation products, PLA<sub>2</sub> β phospholipase A<sub>2</sub>, PT β prothrombin time, TLE β thrombin like enzymes, WBCT β whole blood clotting time, WBCT20 β 20 minutes whole blood clotting time, FII β factor II, FV β factor V, FX β factor X, FDP β fibrinogen degradation products; PTA β prothrombin activator; SVMP β snake venom metalloproteinase; NR β not reported;</p><p>* A SVMP has been isolated from <i>D. typus</i> venom but its function (? PTA, FX activator, TLE) is unclear and only fibrinogen has been measured in patients.</p><p>Summary of snakes known to cause venom-induced consumption coagulopathy, the procoagulant toxin, and the factor deficiencies that have been reported (with permission from WikiToxin).</p
Summary of the randomised comparative trials of treatment for VICC, including antivenom and heparin with details of study size, design, and outcomes.
<p>* Varied based on the clinical assessment of the severity on admission;</p>β <p>May differ from the author's conclusion, see text. Abbreviations: AV β antivenom; WBCT20 β 20-minute whole blood clotting test (or 12-, 15-, or 30-minute); WBC time β whole blood clotting time; IVIG β intravenous immunoglobulin; PT β prothrombin time;</p><p>Summary of the randomised comparative trials of treatment for VICC, including antivenom and heparin with details of study size, design, and outcomes.</p
Summary of the non-randomised studies if VICC comparing two groups.
β <p>May differ to the author's conclusion, see text. Abbreviations: AV β antivenom; WBCT20 β 20 minute whole blood clotting test (or 12, 15 or 30 minute); PT β prothrombin time; aPTT β activated partial thromboplastin time; INR β international normalised ratio; IM β intramuscular; IV - intravenous.</p><p>Summary of the non-randomised studies if VICC comparing two groups.</p
The scoring system adopted to grade the severity of envenoming and the severity of abdominal pain.
<p>The scoring system adopted to grade the severity of envenoming and the severity of abdominal pain.</p
Correlations between abdominal pain severity versus different clinical parameters of the 55 proven Russell's viper bite patients.
<p>(Statistical test -Spearman's rho.).</p
Seasonal variation of Russell's viper bites.
<p>Distribution of the confirmed and suspected cases of Russell's viper bites admitted to the Teaching Hospital, Anuradhapura from January to December, 2010. Note the high rate of admissions during February β April and September β November representing paddy harvesting and chena cultivation seasons.</p
Systemic involvement of the proven Russell's viper bite patients (nβ=β55) (percentages within parenthesis).
<p>Systemic involvement of the proven Russell's viper bite patients (nβ=β55) (percentages within parenthesis).</p
Clinical findings of the 55 proven and 154 suspected Russell's viper bite patients. (percentages within parenthesis).
<p>Clinical findings of the 55 proven and 154 suspected Russell's viper bite patients. (percentages within parenthesis).</p
Correlations between length of the snake versus different clinical parameters of 48 from the 55 confirmed Russell's viper bite patients.
<p>(Statistical test -Spearman's rho.).</p
The numbers of antivenom vials and antivenom cycles received by the proven and probable Russell's viper bite patients.
<p>(Percentages within parenthesis.).</p